| Variables . | Rapid GFR decline (>3 mL/min/1.73 m2) . | P-values . | |
|---|---|---|---|
| Yes (n = 144) . | No (n = 375) . | ||
| Age (years) | 34 ± 9 | 37 ± 9 | <0.0001 |
| Duration (years) | 21 ± 8 | 24 ± 9 | 0.003 |
| Male (%) | 38 | 46 | 0.31 |
| HbA1c (%) | 8.0 ± 1.5 | 7.9 ± 1.2 | 0.52 |
| SBP (mm Hg) | 115 ± 15 | 117 ± 13 | 0.31 |
| LDL-C (mg/dL) | 95 ± 27 | 101 ± 28 | 0.02 |
| eIS | 4.4 ± 1.6 | 4.4 ± 1.6 | 0.93 |
| ACRa (mg/g) | 11 (9–15) | 9 (8–10) | 0.08 |
| CKD-EPI creatinine | 121 ± 20 | 98 ± 25 | <0.0001 |
| Renal hyperfiltration (%) (n = 147) | 54 | 18 | <0.0001 |
| Incident eGFR < 60 mL/min/1.73 m2 at 6-year follow-up (%) (n = 15) | 9 | 0.6 | <0.0001 |
| Variables . | Rapid GFR decline (>3 mL/min/1.73 m2) . | P-values . | |
|---|---|---|---|
| Yes (n = 144) . | No (n = 375) . | ||
| Age (years) | 34 ± 9 | 37 ± 9 | <0.0001 |
| Duration (years) | 21 ± 8 | 24 ± 9 | 0.003 |
| Male (%) | 38 | 46 | 0.31 |
| HbA1c (%) | 8.0 ± 1.5 | 7.9 ± 1.2 | 0.52 |
| SBP (mm Hg) | 115 ± 15 | 117 ± 13 | 0.31 |
| LDL-C (mg/dL) | 95 ± 27 | 101 ± 28 | 0.02 |
| eIS | 4.4 ± 1.6 | 4.4 ± 1.6 | 0.93 |
| ACRa (mg/g) | 11 (9–15) | 9 (8–10) | 0.08 |
| CKD-EPI creatinine | 121 ± 20 | 98 ± 25 | <0.0001 |
| Renal hyperfiltration (%) (n = 147) | 54 | 18 | <0.0001 |
| Incident eGFR < 60 mL/min/1.73 m2 at 6-year follow-up (%) (n = 15) | 9 | 0.6 | <0.0001 |
Data are presented as mean ± standard deviation, unless otherwise specified.
aGeometric means ± 95% confidence interval.
| Variables . | Rapid GFR decline (>3 mL/min/1.73 m2) . | P-values . | |
|---|---|---|---|
| Yes (n = 144) . | No (n = 375) . | ||
| Age (years) | 34 ± 9 | 37 ± 9 | <0.0001 |
| Duration (years) | 21 ± 8 | 24 ± 9 | 0.003 |
| Male (%) | 38 | 46 | 0.31 |
| HbA1c (%) | 8.0 ± 1.5 | 7.9 ± 1.2 | 0.52 |
| SBP (mm Hg) | 115 ± 15 | 117 ± 13 | 0.31 |
| LDL-C (mg/dL) | 95 ± 27 | 101 ± 28 | 0.02 |
| eIS | 4.4 ± 1.6 | 4.4 ± 1.6 | 0.93 |
| ACRa (mg/g) | 11 (9–15) | 9 (8–10) | 0.08 |
| CKD-EPI creatinine | 121 ± 20 | 98 ± 25 | <0.0001 |
| Renal hyperfiltration (%) (n = 147) | 54 | 18 | <0.0001 |
| Incident eGFR < 60 mL/min/1.73 m2 at 6-year follow-up (%) (n = 15) | 9 | 0.6 | <0.0001 |
| Variables . | Rapid GFR decline (>3 mL/min/1.73 m2) . | P-values . | |
|---|---|---|---|
| Yes (n = 144) . | No (n = 375) . | ||
| Age (years) | 34 ± 9 | 37 ± 9 | <0.0001 |
| Duration (years) | 21 ± 8 | 24 ± 9 | 0.003 |
| Male (%) | 38 | 46 | 0.31 |
| HbA1c (%) | 8.0 ± 1.5 | 7.9 ± 1.2 | 0.52 |
| SBP (mm Hg) | 115 ± 15 | 117 ± 13 | 0.31 |
| LDL-C (mg/dL) | 95 ± 27 | 101 ± 28 | 0.02 |
| eIS | 4.4 ± 1.6 | 4.4 ± 1.6 | 0.93 |
| ACRa (mg/g) | 11 (9–15) | 9 (8–10) | 0.08 |
| CKD-EPI creatinine | 121 ± 20 | 98 ± 25 | <0.0001 |
| Renal hyperfiltration (%) (n = 147) | 54 | 18 | <0.0001 |
| Incident eGFR < 60 mL/min/1.73 m2 at 6-year follow-up (%) (n = 15) | 9 | 0.6 | <0.0001 |
Data are presented as mean ± standard deviation, unless otherwise specified.
aGeometric means ± 95% confidence interval.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
